"Designing Growth Strategies is in our DNA"

Familial Amyloid Polyneuropathy Therapeutics Market Size, Share & Industry Analysis By Drug Type (Inotersen, Tafamidis, Patisiran), By Disease Type (Familial Amyloid Polyneuropathy-I (FAP-I), Familial Amyloid Polyneuropathy-II (FAP-II), Familial Amyloid Polyneuropathy-III (FAP-III)), By Gender Type (Male, Female), By Distribution Channel (Hospital Pharmacies, Retail pharmacies) Others and Regional Forecast, 2022-2029

Region : Global | Report ID: FBI102086 | Status : Ongoing

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Final report will be updated to address the impact of COVID-19 on this particular market

Speak to Analyst

Refresh Button
Booklet
  • Ongoing
  • 2021
  • 2018-2020

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X